GROSSMAN, TAMAR, R.,MCCALEB, MICHAEL, L.,WATT, ANDREW, T.,FREIER, SUSAN, M.
申请号：
SG11201601445X
公开号：
SG11201601445XA
申请日:
2014.09.12
申请国别(地区):
SG
年份:
2016
代理人:
摘要：
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.
